spacer
spacer

PDBsum entry 1jbi

Go to PDB code: 
protein links
Structural genomics, unknown function PDB id
1jbi
Jmol
Contents
Protein chain
100 a.a. *
* Residue conservation analysis
PDB id:
1jbi
Name: Structural genomics, unknown function
Title: Nmr structure of the lccl domain
Structure: Cochlin. Chain: a. Fragment: lccl module. Synonym: coch-5b2. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: m13mp18. Expressed in: escherichia coli. Expression_system_taxid: 562.
NMR struc: 20 models
Authors: E.Liepinsh,M.Trexler,A.Kaikkonen,J.Weigelt,L.Banyai, L.Patthy,G.Otting
Key ref:
E.Liepinsh et al. (2001). NMR structure of the LCCL domain and implications for DFNA9 deafness disorder. EMBO J, 20, 5347-5353. PubMed id: 11574466 DOI: 10.1093/emboj/20.19.5347
Date:
05-Jun-01     Release date:   17-Oct-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O43405  (COCH_HUMAN) -  Cochlin
Seq:
Struc:
 
Seq:
Struc:
550 a.a.
100 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 

 
DOI no: 10.1093/emboj/20.19.5347 EMBO J 20:5347-5353 (2001)
PubMed id: 11574466  
 
 
NMR structure of the LCCL domain and implications for DFNA9 deafness disorder.
E.Liepinsh, M.Trexler, A.Kaikkonen, J.Weigelt, L.Bányai, L.Patthy, G.Otting.
 
  ABSTRACT  
 
The LCCL domain is a recently discovered, conserved protein module named after its presence in Limulus factor C, cochlear protein Coch-5b2 and late gestation lung protein Lgl1. The LCCL domain plays a key role in the autosomal dominant human deafness disorder DFNA9. Here we report the nuclear magnetic resonance (NMR) structure of the LCCL domain from human Coch-5b2, where dominant mutations leading to DFNA9 deafness disorder have been identified. The fold is novel. Four of the five known DFNA9 mutations are shown to involve at least partially solvent-exposed residues. Except for the Trp91Arg mutant, expression of these four LCCL mutants resulted in misfolded proteins. These results suggest that Trp91 participates in the interaction with a binding partner. The unexpected sensitivity of the fold with respect to mutations of solvent-accessible residues might be attributed to interference with the folding pathway of this disulfide-containing domain.
 
  Selected figure(s)  
 
Figure 1.
Figure 1 Multiple alignment of the amino acid sequences of LCCL domains. The top sequence is the construct used in the present study. The residues of the construct are numbered from 1 to 100. This numbering is used throughout this article and differs by 26 from the residue numbering by Trexler et al. (2000). The construct thus comprises residues 28 -124 of human Coch-5b2 (positions indicated by arrows) and contains three additional residues at the termini from the expression system used (shown in italics). The locations of the -helix and -strands in human Coch-5b2 are shown at the top. The following sequences are from mouse Coch-5b2 (Coch-5b2_mouse, residues 30 -126), chicken Coch-5b2 (Coch-5b2_chicken, residues 24 -120), the two LCCL domains of the human CocoaCrisp protein (CocoaCrisp_hu_1, residues 289 -387, and CocoaCrisp_hu_2, residues 390 -497), the two LCCL domains of rat late gestation lung protein Lgl1 (Lgl11_rat, residues 224 -322, and Lgl12_rat, residues 325 -433), Limulus factor C (Lfc_tactr, residues 325 -424), a predicted protein of P. falciparum (DDBJ/EMBL/GenBank accession No. AL031745), the predicted human Coch-5b2-related protein (DDBJ/EMBL/GenBank accession No. AAF19243, residues 40 -136) and the predicted human Cub-1 protein (Cub1_human, residues 116 -213). To highlight conserved features of the LCCL domain, similar residues present in more than half of the LCCL modules are shaded. Crosses mark the locations of residues, where mutations in the human Coch-5b2 protein correlate with the deafness disorder DFNA9.
Figure 2.
Figure 2 Solution structure of the LCCL domain of human Coch-5b2. (A) Ribbon representation. The disulfide bonds are shown in a ball-and-stick representation. The -strands are numbered as in Figure 1. (B) Ribbon representation as in (A), but in a different orientation. (C) Stereo view showing a superposition of the backbone atoms in the 20 conformers representing the NMR structure (Table I), in a similar orientation to that in (A). Approximately every tenth residue is identified by its sequence number. In addition, black arrows and sequence numbers identify the locations of the five known DFNA9 mutations. (D) Stereo view of the conformer closest to the mean structure of the 20 conformers shown in (C), using a heavy atom representation in the same orientation as in (C). The polypeptide backbone is drawn in purple. The following colors were used for the side chains: blue, Arg, Lys; red, Glu, Asp; yellow, Ala, Cys, Ile, Leu, Met, Phe, Pro, Trp, Val; gray, Asn, Gln, His, Ser, Thr, Tyr. Bold lines label the backbone of the residues mutated in the deafness disorder DFNA9 (Pro25, Val40, Gly62, Ile 83, Trp91) and the two disulfide bridges. Spheres and residue numbers highlight the C^ atoms of the fully conserved residues Gly55 and Asn81, and of residue 78, where all LCCL domains have an uncharged and solvent-exposed residue (Figures 1 and 3).
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: EMBO J (2001, 20, 5347-5353) copyright 2001.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20662919 J.Shi, X.Jiao, T.Song, B.Zhang, C.Qin, and F.Cao (2010).
CRISPLD2 polymorphisms are associated with non-syndromic cleft lip with or without cleft palate in a northern Chinese population.
  Eur J Oral Sci, 118, 430-433.  
21046548 M.S.Hildebrand, L.Gandolfo, A.E.Shearer, J.A.Webster, M.Jensen, W.J.Kimberling, D.Stephan, P.L.Huygen, R.J.Smith, and M.Bahlo (2010).
A novel mutation in COCH-implications for genotype-phenotype correlations in DFNA9 hearing loss.
  Laryngoscope, 120, 2489-2493.  
19161137 M.S.Hildebrand, D.Tack, A.Deluca, I.A.Hur, J.M.Van Rybroek, S.J.McMordie, A.Muilenburg, D.P.Hoskinson, G.Van Camp, M.L.Pensak, I.S.Storper, P.L.Huygen, T.L.Casavant, and R.J.Smith (2009).
Mutation in the COCH gene is associated with superior semicircular canal dehiscence.
  Am J Med Genet A, 149, 280-285.  
19304662 N.Simon, S.M.Scholz, C.K.Moreira, T.J.Templeton, A.Kuehn, M.A.Dude, and G.Pradel (2009).
Sexual Stage Adhesion Proteins Form Multi-protein Complexes in the Malaria Parasite Plasmodium falciparum.
  J Biol Chem, 284, 14537-14546.  
18784944 K.Vrijens, L.Van Laer, and G.Van Camp (2008).
Human hereditary hearing impairment: mouse models can help to solve the puzzle.
  Hum Genet, 124, 325-348.  
18697796 N.G.Robertson, S.M.Jones, T.A.Sivakumaran, A.B.Giersch, S.A.Jurado, L.M.Call, C.E.Miller, S.F.Maison, M.C.Liberman, and C.C.Morton (2008).
A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.
  Hum Mol Genet, 17, 3426-3434.  
17926100 P.K.Kommareddi, T.S.Nair, Y.Raphael, S.A.Telian, A.H.Kim, H.A.Arts, H.K.El-Kashlan, and T.E.Carey (2007).
Cochlin isoforms and their interaction with CTL2 (SLC44A2) in the inner ear.
  J Assoc Res Otolaryngol, 8, 435-446.  
17662637 R.Picciani, K.Desai, J.Guduric-Fuchs, T.Cogliati, C.C.Morton, and S.K.Bhattacharya (2007).
Cochlin in the eye: functional implications.
  Prog Retin Eye Res, 26, 453-469.  
16835921 R.W.Collin, R.J.Pauw, J.Schoots, P.L.Huygen, L.H.Hoefsloot, C.W.Cremers, and H.Kremer (2006).
Identification of a novel COCH mutation, G87W, causing autosomal dominant hearing impairment (DFNA9).
  Am J Med Genet A, 140, 1791-1794.  
16151339 M.H.Kemperman, E.M.De Leenheer, P.L.Huygen, G.van Duijnhoven, C.C.Morton, N.G.Robertson, F.P.Cremers, H.Kremer, and C.W.Cremers (2005).
Audiometric, vestibular, and genetic aspects of a DFNA9 family with a G88E COCH mutation.
  Otol Neurotol, 26, 926-933.  
16332271 S.K.Bhattacharya, N.S.Peachey, and J.W.Crabb (2005).
Cochlin and glaucoma: a mini-review.
  Vis Neurosci, 22, 605-613.  
16078052 T.Makishima, C.I.Rodriguez, N.G.Robertson, C.C.Morton, C.L.Stewart, and A.J.Griffith (2005).
Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder.
  Hum Genet, 118, 29-34.  
12843317 N.G.Robertson, S.A.Hamaker, V.Patriub, J.C.Aster, and C.C.Morton (2003).
Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9.
  J Med Genet, 40, 479-486.  
12354219 C.Claudianos, J.T.Dessens, H.E.Trueman, M.Arai, J.Mendoza, G.A.Butcher, T.Crompton, and R.E.Sinden (2002).
A malaria scavenger receptor-like protein essential for parasite development.
  Mol Microbiol, 45, 1473-1484.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.